| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 47.06% | Morgan Stanley | $2.5 → $1.75 | Maintains | Equal-Weight |
| 08/03/2023 | 110.08% | Morgan Stanley | $5 → $2.5 | Downgrades | Overweight → Equal-Weight |
| 05/04/2023 | 194.12% | Credit Suisse | $4 → $3.5 | Maintains | Neutral |
| 03/23/2023 | 110.08% | TD Cowen | $5 → $2.5 | Downgrades | Outperform → Market Perform |
| 03/15/2023 | 320.17% | Guggenheim | → $5 | Reiterates | → Buy |
| 03/13/2023 | 320.17% | Morgan Stanley | $6 → $5 | Maintains | Overweight |
| 02/27/2023 | 194.12% | Piper Sandler | $5 → $3.5 | Downgrades | Overweight → Neutral |
| 02/23/2023 | — | Needham | Maintains | Hold | |
| 02/23/2023 | 236.13% | Credit Suisse | $5 → $4 | Maintains | Neutral |
| 01/06/2023 | 404.2% | Morgan Stanley | $7 → $6 | Maintains | Overweight |
| 01/04/2023 | 252.94% | B of A Securities | → $4.2 | Upgrades | Neutral → Buy |
| 09/07/2022 | 320.17% | Truist Securities | → $5 | Initiates Coverage On | → Hold |
| 09/07/2022 | 320.17% | Piper Sandler | $6 → $5 | Maintains | Overweight |
| 06/23/2022 | 404.2% | Piper Sandler | $5 → $6 | Maintains | Overweight |
| 05/17/2022 | 320.17% | Piper Sandler | $7 → $5 | Maintains | Overweight |
| 05/10/2022 | 488.24% | Morgan Stanley | $9 → $7 | Maintains | Overweight |
| 02/28/2022 | 236.13% | Wells Fargo | $6 → $4 | Maintains | Equal-Weight |
| 12/17/2021 | 656.3% | Morgan Stanley | $12 → $9 | Maintains | Overweight |
| 12/02/2021 | 404.2% | Jefferies | → $6 | Initiates Coverage On | → Hold |
| 11/11/2021 | 824.37% | Credit Suisse | $13.5 → $11 | Maintains | Neutral |
| 09/14/2021 | 1160.5% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 08/31/2021 | 1244.54% | Morgan Stanley | $18 → $16 | Maintains | Overweight |
| 08/24/2021 | 2000.84% | Cowen & Co. | $29 → $25 | Maintains | Outperform |
| 08/12/2021 | 1034.45% | Credit Suisse | $17.5 → $13.5 | Maintains | Neutral |
| 07/02/2021 | 1412.61% | Morgan Stanley | $32 → $18 | Maintains | Overweight |
| 05/17/2021 | 1160.5% | Guggenheim | → $15 | Upgrades | Neutral → Buy |
| 05/13/2021 | 1370.59% | Credit Suisse | $23 → $17.5 | Maintains | Neutral |
| 04/16/2021 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 04/15/2021 | — | Needham | Initiates Coverage On | → Hold | |
| 03/26/2021 | 2589.08% | Morgan Stanley | $33 → $32 | Maintains | Overweight |
| 01/28/2021 | 3345.38% | Credit Suisse | → $41 | Downgrades | Outperform → Neutral |
| 01/07/2021 | — | BTIG | Initiates Coverage On | → Neutral | |
| 12/18/2020 | 2336.97% | Stifel | → $29 | Initiates Coverage On | → Hold |
| 10/23/2020 | — | Guggenheim | Initiates Coverage On | → Neutral | |
| 10/12/2020 | 2336.97% | UBS | → $29 | Initiates Coverage On | → Neutral |
| 10/12/2020 | 2841.18% | Morgan Stanley | → $35 | Initiates Coverage On | → Equal-Weight |
| 10/12/2020 | 3345.38% | Cowen & Co. | → $41 | Initiates Coverage On | → Outperform |
What is the target price for American Well (AMWL)?
The latest price target for American Well (NYSE: AMWL) was reported by Morgan Stanley on November 2, 2023. The analyst firm set a price target for $1.75 expecting AMWL to rise to within 12 months (a possible 47.06% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for American Well (AMWL)?
The latest analyst rating for American Well (NYSE: AMWL) was provided by Morgan Stanley, and American Well maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for American Well (AMWL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Well, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Well was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating American Well (AMWL) correct?
While ratings are subjective and will change, the latest American Well (AMWL) rating was a maintained with a price target of $2.50 to $1.75. The current price American Well (AMWL) is trading at is $1.19, which is out of the analyst's predicted range.